InvestorsHub Logo
Followers 1
Posts 70
Boards Moderated 0
Alias Born 03/12/2019

Re: None

Wednesday, 10/06/2021 8:48:04 AM

Wednesday, October 06, 2021 8:48:04 AM

Post# of 871
Oral LNC/Remdesivir may not only be more efficacious, but safer!

Which would you opt for?
- Remdesivir blocks replication
- Molnupiravir propagates errors in replication

"both molnupiravir and Veklury are incorporated by the viral RNA polymerase, with molnupiravir being a viral genome mutagen and Veklury blocking replication done by the polymerase"

"Side effect concerns have been raised about whether molnupiravir could be metabolised into a precursor of DNA, Swanstrom said, explaining it could enter the host cell nucleus, leading to oncogenesis."

https://www.clinicaltrialsarena.com/comment/ridgeback-mercks-molnupiravir-for-covid-19-has-moa-administration-advantages-but-phase-iia-faces-execution-obstacles-may-have-value-gaps/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTNB News